RGRui Gu

Rui Gu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rui Gu has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Wenqi Luo

    14 shared publications
  • Wanguo Liu

    Department of Orthopaedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, People's Republic of China

    12 shared publications
  • Chunyu Xiang

    Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, P. R. China

    9 shared publications
  • Jianhui Zhao

    Department of Spine Surgery, China-Japan Union Hospital of Jilin University, China

    8 shared publications
  • Fengshuo Guo

    Department of Orthopedic Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, P. R. China

    6 shared publications
  • Renrui Niu

    Department of Orthopedic Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China

    6 shared publications

Latest Publications

  • Open Access

    A zinc-coordinated cascade-responsive therapeutic nanoassembly for remodeling the pathological microenvironment and restoring mitochondrial homeostasis in spinal cord injury

    by Chunyu Xiang, Xiaodong He, Fengshuo Guo, Haowen Luo, Liumin He, Wanguo Liu, Rui Gu

    Secondary injury after spinal cord injury (SCI) is sustained by coupled oxidative stress and inflammation, which drives neuronal apoptosis and bioenergetic failure. Here, a cascade-responsive Zn2+-centered nanoassembly (Zn-PC/PA@Gel) is constructed through stepwise coordination among Zn2+, procyanidin (PC), and polyarginine (PA) to form a core-shell architecture with a Zn2+-procyanidin core (Zn-PC) and a Zn2+-polyarginine shell (Zn-PA). In a reactive oxygen species (ROS) rich injury microenvironment, oxidation of guanidino groups in the polyarginine shell enables in situ nitric oxide (NO) release and weakens Zn2+ coordination, triggering controlled shell disassembly for early modulation of local inflammation and tissue microenvironment. The subsequent release of PC and Zn2+ provides continuous antioxidant protection. Zn2+ further restores mitochondrial quality control by regulating the STAT3-FOXO3a-SOD2 axis, thus enhancing mitochondrial autophagy, enhancing endogenous antioxidant defense, and restoring mitochondrial homeostasis and energy metabolism. In a mouse spinal cord contusion model, Zn-PC/PA@Gel mitigated inflammation and oxidative stress, alleviated the burden of mitochondrial dysfunction, protected neurons, and promoted motor recovery, resulting in a Basso Mouse Scale (BMS) score of 7.0 on day 28. Overall, these results support Zn2+ coordinated cascade therapy nanoassembly, which combines microenvironmental regulation with mitochondrial homeostatic recovery to reduce secondary injury after SCI and promote locomotor improvement.

  • Efficient combined use of electroacupuncture with ordered collagen scaffolds enhances the therapeutic efficacy of human spinal cord-derived neural progenitor cells therapy in spinal cord injury rats

    by Yunlong Zou, Weiwei Xue, Bo Guo, Lu Li, Yannan Zhao, Xianming Wu, Zhifeng Xiao, Qi Zhang, Dezun Ma, Xinhao Zhao, et al.

    Most spinal cord injury (SCI) patients experience severe morbidity and permanent disability. Currently, effective clinical treatments remain limited. Beyond direct nerve damage, spinal cord lesions result in atrophy of lower limb muscles, thereby impeding motor function recovery. Our therapeutic approach for repairing complete SCI combines traditional Chinese electroacupuncture stimulation of the Jiaji (EX-B2) and Zusanli (ST36) acupoints with the transplantation of human spinal cord-derived neural progenitor cells (hsc-NPCs) delivered on an ordered collagen scaffold. Results indicated that electroacupuncture was applied both to enhance the efficacy of hsc-NPCs therapy for nerve regeneration at the lesion site and to prevent muscle atrophy, contributing to motor function recovery. This innovative approach integrates Eastern and Western medical perspectives to pursue breakthroughs in SCI treatment.

  • Open Access

    Copper-hollow mesoporous polydopamine-polyacrylic acid nanoplatform enabling photoacoustic imaging-guided photothermal/chemodynamic therapy for osteosarcoma

    by Haoyu Sun, Zeping Liu, Bowen Chen, Yunkai Bao, Fenghua Li, Rui Gu, Zhenxin Wang

    HMPDA-Cu@PAA nanozymes enable photoacoustic imaging (PAI)-guided CDT–PTT therapy via GSH-responsive Cu 2+ /Cu + redox cycling in osteosarcoma.


  • Open Access

    The Design Strategies and Applications of Engineered Nanoparticles for Traumatic Brain Injury

    by Chunyu Xiang, Yuhang Zhu, Xu Gao, Fengshuo Guo, Xiaodong He, Wenqi Luo, Wanguo Liu, Rui Gu

    Traumatic brain injury (TBI) is a serious neurological condition. Because of its complex pathophysiological processes, direct treatment options are extremely limited. A key reason for this is the blood-brain barrier (BBB), which makes it difficult for conventional drug molecules to penetrate and maintain effective concentrations in brain tissue. In recent years, nanoparticles have garnered significant attention due to their unique biological properties, enhanced therapeutic effects, and low toxicity. By modifying the surface of nanoparticles with targeting ligands, their penetration capacity can be significantly enhanced, enabling directed delivery to the core injury area and substantially increasing their accumulation at the site of injury. Furthermore, functionally engineered nanoparticles can respond to specific signals in the TBI microenvironment, such as reactive oxygen species (ROS), enzymes, and pH changes, thereby enabling controlled drug release and significantly improving delivery efficiency. This review systematically summarizes the latest advances in engineered nanoparticles for TBI treatment from three perspectives: rational design, therapeutic strategies, and clinical translation.


  • Open Access

    Generation and clearance of myelin debris after spinal cord injury

    by Chaoyuan Li, Wenqi Luo, Irshad Hussain, Renrui Niu, Xiaodong He, Chunyu Xiang, Fengshuo Guo, Wanguo Liu, Rui Gu

    Traumatic spinal cord injury often leads to the disintegration of nerve cells and axons, resulting in a substantial accumulation of myelin debris that can persist for years. The abnormal buildup of myelin debris at sites of injury greatly impedes nerve regeneration, making the clearance of debris within these microenvironments crucial for effective post-spinal cord injury repair. In this review, we comprehensively outline the mechanisms that promote the clearance of myelin debris and myelin metabolism and summarize their roles in spinal cord injury. First, we describe the composition and characteristics of myelin debris and explain its effects on the injury site. Next, we introduce the phagocytic cells involved in myelin debris clearance, including professional phagocytes (macrophages and microglia) and non-professional phagocytes (astrocytes and microvascular endothelial cells), as well as other cells that are also proposed to participate in phagocytosis. Finally, we focus on the pathways and associated targets that enhance myelin debris clearance by phagocytes and promote lipid metabolism following spinal cord injury. Our analysis indicates that myelin debris phagocytosis is not limited to monocyte-derived macrophages, but also involves microglia, astrocytes, and microvascular endothelial cells. By modulating the expression of genes related to phagocytosis and lipid metabolism, it is possible to modulate lipid metabolism disorders and influence inflammatory phenotypes, ultimately affecting the recovery of motor function following spinal cord injury. Additionally, therapies such as targeted mitochondrial transplantation in phagocytic cells, exosome therapy, and repeated trans-spinal magnetic stimulation can effectively enhance the removal of myelin debris, presenting promising potential for future applications.


  • Open Access

    Isthmic spondylolisthesis combined with schwannoma occurring at the same vertebral level: a case report and literature review

    by Renrui Niu, Jianhui Zhao, Chaoyuan Li, Fengshuo Guo, Yuchi Duan, Wenqi Luo, Rui Gu

    Background: The occurrence of schwannomas at the level of isthmic spondylolisthesis has not yet been reported. Preoperative identification of the responsible lesion and a rational surgical plan are essential for successful surgery.Case presentation: We report the case of a 56-year-old woman who presented with a six-year history of low back pain and a three-year history of radiating pain in the left lower extremity. Physical examination revealed signs of left L5 root compression. Computed tomography revealed left L5–S1 intervertebral foramen stenosis with an isthmic fracture. Unexpectedly, magnetic resonance imaging (MRI) showed an abnormal 12 mm*11 mm*21 mm intradural mass with inhomogeneous contrast enhancement at the level of the spondylolisthesis. Isthmic spondylolisthesis and schwannoma were suspected. Based on the imaging and physical findings, we inferred that the lower-extremity pain was primarily caused by lumbar spondylolisthesis. Under general anesthesia, the patient underwent posterior lumbar interbody fusion of L5–S1 and intradural total tumorectomy. Histopathological examination of the surgical specimen revealed a schwannoma. The patient's symptoms resolved postoperatively, and intervertebral fusion was satisfactory at the 12-month follow-up.Conclusion: This case demonstrates the difficulty of determining the responsible lesion, highlighting the importance of meticulous clinical and imaging examinations. Determining the responsible lesion is crucial for diagnosis and treatment.

  • Open Access

    The Hedgehog–GLI1 Pathway Regulates Osteogenic Differentiation of Human Cervical Posterior Longitudinal Ligament Cells by BMP Signalling Pathway

    by Wenbo Xu, Bingbing Ran, Toshimi Aizawa, Wanguo Liu, Jianhui Zhao, Renrui Niu, Zeping Liu, Rui Gu

    Cervical ossification of the posterior longitudinal ligament (OPLL) is an ectopic ossification disorder characterised by endochondral ossification. Its aetiology remains to be fully elucidated. This study aimed to clarify its pathogenesis through RNA sequencing of primary cells cultured from patients without cervical OPLL (control, PLL) and patients with cervical OPLL (disease, OPLL). We revealed for the first time the role of GLI1 within OPLL cells. Functional experiments indicated that GLI1, acting as a pivotal mediator between the upstream Hedgehog pathway and downstream BMP pathway, influences the pathogenesis of OPLL. The positive/negative effects on osteogenic differentiation following activation/inhibition of the Hedgehog pathway can be rescued by manipulating GLI1 expression. Overexpression of GLI1 activates BMP signalling, enhancing osteogenic capacity in PLL cells, while GLI1 knockdown suppresses BMP signal transduction, attenuating osteogenic differentiation in OPLL cells. Our findings highlight the significant role of the canonical Hedgehog signalling pathway and its interaction with the BMP pathway in the pathogenesis of OPLL.


  • Open Access

    Natural polymer based drug-loaded hydrogel platform for comprehensive care of acute spinal cord injury

    by Mingyu Zhang, Chunyu Xiang, Xin Zhen, Wenqi Luo, Xiaodong He, Fengshuo Guo, Renrui Niu, Wanguo Liu, Rui Gu


  • Open Access

    Regulation of dynamic spatiotemporal inflammation by nanomaterials in spinal cord injury

    by Zeping Liu, Chunyu Xiang, Xu Zhao, Toshimi Aizawa, Renrui Niu, Jianhui Zhao, Fengshuo Guo, Yueying Li, Wenqi Luo, Wanguo Liu, et al.

    Spinal cord injury (SCI) is a common clinical condition of the central nervous system that can lead to sensory and motor impairment below the injury level or permanent loss of function in severe cases. Dynamic spatiotemporal neuroinflammation is vital to neurological recovery, which is collectively constituted by the dynamic changes in a series of inflammatory cells, including microglia, neutrophils, and astrocytes, among others. Immunomodulatory nanomaterials can readily improve the therapeutic effects and simultaneously overcome various drawbacks associated with treatment, such as the off-target side effects and loss of bioactivity of immune agents during circulation. In this review, we discuss the role of dynamic spatiotemporal inflammation in secondary injuries after SCI, elaborate on the mechanism of action and effect of existing nanomaterials in treating SCI, and summarize the mechanism(s) whereby they regulate inflammation. Finally, the challenges and prospects associated with using nanotechnology to modulate immunotherapy are discussed to provide new insights for future treatment. Deciphering the intricate spatiotemporal mechanisms of neuroinflammation in SCI requires further in-depth studies. Therefore, SCI continues to represent a formidable challenge. Graphical abstract


  • Open Access

    Exosomes as promising bioactive materials in the treatment of spinal cord injury

    by Yueying Li, Wenqi Luo, Chuikai Meng, Kaiyuan Shi, Rui Gu, Shusen Cui

    Patients with spinal cord injury (SCI) have permanent devastating motor and sensory disabilities. Secondary SCI is known for its complex progression and presents with sophisticated aberrant inflammation, vascular changes, and secondary cellular dysfunction, which aggravate the primary damage. Since their initial discovery, the potent neuroprotective effects and powerful delivery abilities of exosomes (Exos) have been reported in different research fields, including SCI. In this study, we summarize therapeutic advances related to the application of Exos in preclinical animal studies. Subsequently, we discuss the mechanisms of action of Exos derived from diverse cell types, including neurogenesis, angiogenesis, blood–spinal cord barrier preservation, anti-apoptosis, and anti-inflammatory potential. We also evaluate the relationship between the Exo delivery cargo and signaling pathways. Finally, we discuss the challenges and advantages of using Exos to offer innovative insights regarding the development of efficient clinical strategies for SCI.